Neurological outcomes have been favorable in patients with subacute combined degeneration, who are identified early and treated promptly. However, residual long-term moderate to severe neurological deficits have been noted in some, particularly those that discontinue treatment.

In most patients who have been treated with vitamin B12 supplementation, hematological improvement is rapid with the resolution of hemolysis.